DNTH CIK: 1690585

Dianthus Therapeutics, Inc. /DE/

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−59.5
FY22:
−29.1
FY23:
−36.9
FY24:
−78.2
FY25:
−129
Change from FY21 to FY25
millions USD
FY21:
43.4
FY22:
−59.8
FY23:
20.3
FY24:
−287
FY25:
−123
Change from FY21 to FY25
millions USD
FY21:
89.6
FY22:
96.7
FY23:
134
FY24:
256
FY25:
280
millions USD
FY21:
73.5
FY22:
7.79
FY23:
117
FY24:
−109
FY25:
28.2
(positive)
Change from FY21 to FY22
millions USD
FY21:
−60.8
FY22:
−29.4
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR